1/27
Looks like no tags are added yet.
receptor
protein that spans the plasma membrane of the cell
recognise and bind to agonists and become active
active receptor pass a signal into the interior of the cell to the start of biochemical pathways
results in a useful function (contraction, secretion and growth)
what are some agonists in the body that cause a response
histamine, adrenaline, noradrenaline, acetylcholine, serotonin, angiotensin 2
ligand gated ion channel
ligand binding opens ion channels, allowing ions such as sodium and chlorine to flow, milliseconds
G protein coupled receptor
activating G proteins, producing secondary messengers such as cAMP and IP3, seconds muscarinic ACH receptor
kinase linked receptors
activate receptor associated kinases causing protein phosphorylation and gene expression
nuclear receptors
ligand receptor complex acts as a transcription factor regulates gene expression
affinity and efficacy
affinity - ability to bind
the strength of attraction/binding between a drug and its receptor
high affinity = strong binding
low affinity = weaker binding
higher affinity generally means less drug is required to occupy receptor
efficacy - ability to produce an effect
the ability of an agonist to activate a receptor and produce a response
depends on the ability of the agonist to cause a conformational change In the receptor
determines maximum response a drug can produce
adrenoreceptors receptors
alpha 1 and 2 and beta 1-3
muscarinic receptors
m1-m5
full vs partial agonists
full
produces maximum receptor response
high efficacy
can fully activate a receptors
partial
produces a smaller maximum response
lower efficacy
cannot produce the same maximum response even at full receptor occupancy
agonists may have
different potencies at different receptor subtypes
what does selectivity allow
a drug to target a particular receptor subtype while reducing interactions with others
modifying structures allows
a drug which is specific for one subtype but doesn’t interact with the other
what is potency
potency describes how much drug is required to produce a particular response
more potent drug requires a lower concentration to produce the same effect
less potent drug requires higher concentration
histamine receptors
H1 and H2
receptor are of the same
family but with structural differences in the place where the agonist binds, the structural differences allow drugs to bind more strongly to certain receptor types
what can be exploited to make selective drugs
potency differences for the agonist between each receptor
what do antagonists do
bind to receptors and block the action of agonists
adrenaline example
acts on several adrenoreceptor subtypes, modifying its chemical structures can produce a selective b2 agonist such as salbutamol
antagonists and their properties
bind to receptors and block the action of antagonists
have affinity because they must bind to the receptor
have no efficacy because they do not activate the receptor
prevent or reduce agonist binding and activation
what is competitive antagonism and example
agonist and antagonist compete for receptor binding
increasing antagonist concentration reduces agonist binding
more agonist may be required to produce the same response
produces a rightward shift in the agonist dose response curve
noradrenaline and atenolol compete for B1 receptors, atenolol blocks B1 receptor activation reducing sympathetic effects on the heart
allosteric modulators
bind to different receptor sites from the normal agonist binding site which is called allosteric site
normal agonist binding site is the orthosteric site
positive and negative allosteric modulator
increase and decrease the effect of the agonist
why are positive and negative modulators useful
allosteric sites differ between receptor subtypes allowing greater drug selectivity
can modify receptor activity without necessarily blocking it completely
reduces the risk of excessive receptor inhibition
what are inverse agonists
some GPCRs have activity even when no agonist is present
called constitutive activity
an inverse agonist binds to the receptor and reduces its activity below its normal baseline
pharmacological efficacy
the ability of a drug to activate a receptor and produce a response
clinical efficacy
the ability of a medicine to produce a beneficial therapeutic outcome in a patient
vaccine efficacy and effectiveness
refers to how the vaccine performs in ideal conditions
refers to how the vaccine performs in the wider population